The MISSIONu00aeu00b5u2126 esiRNA targeting human MIR29A is a cutting-edge tool designed for scientists and researchers involved in genetic research and potential therapeutic discoveries. Specifically tailored for advancing the study of microRNAs, this product incorporates state-of-the-art MISSIONu00aeu00b5u2126 esiRNA technology to provide enhanced gene knockdown efficiency.
Human MIR29A is a critical microRNA that plays a crucial role in regulating a wide range of cellular activities, including cell proliferation and extracellular matrix remodeling. Dysregulation of MIR29A has been linked to various diseases, such as cancer, fibrosis, and cardiovascular disorders. By focusing on human MIR29A, scientists can gain valuable insights into its specific roles and potential as a therapeutic target, contributing to our understanding of disease mechanisms and the development of novel treatments.
The MISSIONu00aeu00b5u2126 esiRNA targeting human MIR29A utilizes advanced MISSION technology, which guarantees high specificity and potency in silencing the expression of human MIR29A. esiRNA stands for endoribonuclease-prepared short interfering RNA, which comprises a collection of siRNAs targeting different regions of the mRNA. This heterogeneous set of siRNAs is derived from the enzymatic digestion of longer double-stranded RNA (dsRNA), ensuring maximum knockdown efficiency.
The MISSIONu00aeu00b5u2126 esiRNA targeting human MIR29A has undergone rigorous validation through numerous peer-reviewed studies and technical documents. These validations demonstrate its superior knockdown efficiency compared to other RNA interference methodologies. By effectively reducing the expression of human MIR29A, scientists can unravel its intricate regulatory networks and uncover its significance in various disease contexts.
For comprehensive safety information, please refer to the Material Safety Data Sheet (MSDS) provided with this product.